Cara Therapeutics's total assets for Q3 2024 were $51.33M, a decrease of -29.20% from the previous quarter. CARA total liabilities were $50.62M for the fiscal quarter, a -16.87% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.